These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2652504)

  • 1. The effect of donor age and sex on cyclosporine associated nephrotoxicity.
    Iguro T; Okazaki H; Sato T; Jimbo M; Oguma S
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1554-5. PubMed ID: 2652504
    [No Abstract]   [Full Text] [Related]  

  • 2. Chronic cyclosporine nephrotoxicity in renal transplantation: is it the effect of preservation?
    Kumar MS; Samhan M; John P; al-Adnani MS; Abouna GM
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1552-3. PubMed ID: 2652503
    [No Abstract]   [Full Text] [Related]  

  • 3. The use of triple therapy to minimize cyclosporine (CsA) nephrotoxicity in renal transplantation.
    Landsberg DN; Rae A; Chiu A; Werb R; Taylor P; Chan-Yan C; Manson AD
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1550-1. PubMed ID: 2652502
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of triple therapy on cyclosporine nephrotoxicity and hypertension in renal transplantation.
    Landsberg D; Rae A; Chiu A; Werb R; Taylor P; Chan-Yan C; Manson AD
    Transplant Proc; 1989 Apr; 21(2):3323-4. PubMed ID: 2652826
    [No Abstract]   [Full Text] [Related]  

  • 5. Determinants of cyclosporine nephrotoxicity following cardiac transplantation.
    Martin M; Packham D; Kingswood C; Cairns H; Khaghani A; Thompson D; Yacoub M
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2516-7. PubMed ID: 3274553
    [No Abstract]   [Full Text] [Related]  

  • 6. Overcoming early cyclosporine nephrotoxicity after liver transplantation.
    Burdick JF; Colombani PM; Pitt HA; Perler BA; Merritt WT; Crandall BC; Mitchell MC; Herlong HF; Williams GM
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2236-7. PubMed ID: 2652724
    [No Abstract]   [Full Text] [Related]  

  • 7. Is chronic nephrotoxicity of cyclosporine avoided by the triple drug regimen?
    Hiesse C; Gardin JP; Lantz O; Cantarovich M; Bensadoun H; Benoit G; Bellamy J; Paillard M; Charpentier B; Fries D
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1534-6. PubMed ID: 2652495
    [No Abstract]   [Full Text] [Related]  

  • 8. Amplification of the nephrotoxic effect of cyclosporine by preexistent chronic histological lesions in the kidney.
    Leunissen KM; Bosman FT; Nieman FH; Kootstra G; Vromen MA; Noordzij TC; van Hooff JP
    Transplantation; 1989 Oct; 48(4):590-3. PubMed ID: 2799911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclosporine nephrotoxicity and the consequences of conversion to azathioprine.
    Chapman JR; Morris PJ
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):254-60. PubMed ID: 3895664
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of cyclosporine A on renal graft function is dependent on donor age.
    Leunissen KM; Bosman FT; Kootstra G; van Hooff JP
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):207-8. PubMed ID: 3291244
    [No Abstract]   [Full Text] [Related]  

  • 11. Baseline biopsies define cyclosporine nephrotoxicity.
    Belnap LP; Hammond EH; Yowell R; Richards KF; Rees WV; Stevens LE
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1485. PubMed ID: 2652476
    [No Abstract]   [Full Text] [Related]  

  • 12. Cyclosporine use in early graft dysfunction.
    Gonwa TA; Nghiem DD; Schulak JA; Corry RJ
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):104-12. PubMed ID: 3515675
    [No Abstract]   [Full Text] [Related]  

  • 13. Steroid withdrawal in cyclosporine-treated living related donor renal transplant recipients.
    Kupin W; Venkat KK; Oh HK
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1623-4. PubMed ID: 2652528
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term results of cyclosporine treatment in renal transplantation.
    Tilney NL; Milford EL; Carpenter CB; Lazarus JM; Strom TB; Kirkman RL
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):179-85. PubMed ID: 3083548
    [No Abstract]   [Full Text] [Related]  

  • 15. Cyclosporine nephrotoxicity and dermal vascular alterations in renal transplants.
    Shen SY; Wood C; Amin AN; Papadimitriou JC; Weir MR; Coughlin TR
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1508-10. PubMed ID: 2652486
    [No Abstract]   [Full Text] [Related]  

  • 16. Cyclosporine, azathioprine, and prednisone as treatment for cyclosporine-induced nephrotoxicity in renal transplant recipients.
    Lorber MI; Flechner SM; Van Buren CT; Kerman RH; Kahan BD
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):282-5. PubMed ID: 3895668
    [No Abstract]   [Full Text] [Related]  

  • 17. Cessation of steroids in renal allograft recipients on combined cyclosporine A, azathioprine, and prednisolone.
    O'Connell P; d'Apice A; Walker R; Francis D; Kincaid-Smith P
    Transplant Proc; 1988 Feb; 20(1):11-3. PubMed ID: 3278450
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of cyclosporine on long-term function in patients undergoing kidney transplant from living donors.
    Alfani D; Berloco P; Renna Molajoni E; Pretagostini R; Famulari A; Sallustio F; Caricato M; Rossi M; Pecorella I; Ciardi A
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1759-60. PubMed ID: 3274421
    [No Abstract]   [Full Text] [Related]  

  • 19. Chronic cyclosporine-associated nephrotoxicity.
    Porter GA; Bennett WM
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):204-9. PubMed ID: 3515689
    [No Abstract]   [Full Text] [Related]  

  • 20. Conversion from standard cyclosporine to low-dose cyclosporine in liver transplant recipients: effect on nephrotoxicity and hypertension beyond one year.
    Eid A; Perkins JD; Rakela J; Krom RA
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2238-9. PubMed ID: 2652725
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.